Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Establishment Labs Holdings Inc (NQ: ESTA )

46.25 -1.87 (-3.89%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,476,048
Open 42.65
Bid (Size) 43.56 (1)
Ask (Size) 51.50 (1)
Prev. Close 48.12
Today's Range 42.01 - 49.32
52wk Range 19.84 - 60.12
Shares Outstanding 23,739,353
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Establishment Labs Announces $50 Million Registered Direct Offering
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Third Quarter 2024 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire

Performance

YTD
+73.94%
+73.94%
1 Month
+11.93%
+11.93%
3 Month
+11.47%
+11.47%
6 Month
-17.35%
-17.35%
1 Year
+103.03%
+103.03%

More News

Read More
Exploring Establishment Labs Hldgs's Earnings Expectations
Via Benzinga
Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants
From Establishment Labs Holdings Inc.
Via Business Wire
Critical Insights From Establishment Labs Hldgs Analyst Ratings: What You Need To Know
Via Benzinga
Deep Dive Into Establishment Labs Hldgs Stock: Analyst Perspectives (5 Ratings)
Via Benzinga
The Analyst Landscape: 5 Takes On Establishment Labs Hldgs
Via Benzinga
Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Publishes 2024 Post Market Surveillance Report
From Establishment Labs Holdings Inc.
Via Business Wire
First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants
From Establishment Labs Holdings Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Establishment Labs Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Establishment Labs Receives U.S. FDA Approval for Motiva Implants
From Establishment Labs Holdings Inc.
Via Business Wire
ESTA Stock Earnings: Establishment Labs Hldgs Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Establishment Labs Reports Second Quarter 2024 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Second Quarter 2024 Financial Results on August 6
From Establishment Labs Holdings Inc.
Via Business Wire
Findell Capital Management LLC Releases Comprehensive Research Coverage Report on Nasdaq:ESTA
Via Get News
Exposures Product Safety
Findell Capital Management LLC Releases Comprehensive Research Coverage Report on ESTA: Nasdaq
Via News Direct
Findell Capital Management LLC Releases Comprehensive Research Coverage Report on ESTA: Nasdaq
Via TheNewswire.com
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
ESTA Stock Earnings: Establishment Labs Hldgs Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Establishment Labs Reports First Quarter 2024 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
From Establishment Labs Holdings Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.